This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v1.0.0-ballot: STU 1 Ballot 3) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-dexamethasone-exclude | Version: 1.0.0-ballot | |||
Draft as of 2018-07-02 | Computable Name: Valueset_dexamethasone_exclude | |||
Copyright/Legal: (copyright expectations unknown) |
ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations.
To refine valueset for Warfarin + NSAID PDDI-CDS
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://www.nlm.nih.gov/research/umls/rxnorm
Code | Display |
1009392 | Dexamethasone 1 MG/ML / Neomycin 3.2 MG/ML / Thiabendazole 40 MG/ML Topical Solution [Tresaderm] |
208591 | Dexamethasone 1 MG/ML / Neomycin 3.5 MG/ML / Polymyxin B 10000 UNT/ML Ophthalmic Suspension [Maxitrol] |
208601 | Dexamethasone 0.001 MG/MG / Neomycin 0.0035 MG/MG / Polymyxin B 10 UNT/MG Ophthalmic Ointment [Maxitrol] |
205669 | Dexamethasone 1 MG/ML Ophthalmic Suspension [Maxidex] |
688245 | Dexamethasone 0.0005 MG/MG Ophthalmic Ointment [Maxidex] |
208593 | Dexamethasone 1 MG/ML / Neomycin 3.5 MG/ML / Polymyxin B 10000 UNT/ML Ophthalmic Suspension [Poly-Dex] |
208602 | Dexamethasone 0.001 MG/MG / Neomycin 0.0035 MG/MG / Polymyxin B 10 UNT/MG Ophthalmic Ointment [Poly-Dex] |
1011080 | Dexamethasone 0.5 MG/ML / Tobramycin 3 MG/ML Ophthalmic Suspension [Tobradex] |
208813 | Dexamethasone 1 MG/ML / Tobramycin 3 MG/ML Ophthalmic Suspension [Tobradex] |
208821 | Dexamethasone 0.001 MG/MG / Tobramycin 0.003 MG/MG Ophthalmic Ointment [Tobradex] |
1009391 | Dexamethasone / Neomycin / Thiabendazole Topical Solution [Tresaderm] |
365842 | Dexamethasone Ophthalmic Suspension [Maxidex] |
365818 | Dexamethasone / Neomycin / Polymyxin B Ophthalmic Suspension [Poly-Dex] |
367266 | Dexamethasone / Neomycin / Polymyxin B Ophthalmic Ointment [Poly-Dex] |
688244 | Dexamethasone Ophthalmic Ointment [Maxidex] |
405941 | Ciprofloxacin / Dexamethasone Otic Suspension [Ciprodex] |
93249 | Dexamethasone / Neomycin / Polymyxin B Ophthalmic Ointment [Maxitrol] |
93250 | Dexamethasone / Neomycin / Polymyxin B Ophthalmic Suspension [Maxitrol] |
94334 | Dexamethasone / Tobramycin Ophthalmic Suspension [Tobradex] |
94335 | Dexamethasone / Tobramycin Ophthalmic Ointment [Tobradex] |
1009388 | Dexamethasone 1 MG/ML / Neomycin 3.2 MG/ML / Thiabendazole 40 MG/ML Topical Solution |
226343 | Dexamethasone 1 MG/ML Ophthalmic Solution |
227142 | Dexamethasone 1 MG/ML / hypromellose 5 MG/ML Ophthalmic Solution |
309680 | Dexamethasone 1 MG/ML / Neomycin 3.5 MG/ML / Polymyxin B 10000 UNT/ML Ophthalmic Suspension |
309683 | Dexamethasone 1 MG/ML / Tobramycin 3 MG/ML Ophthalmic Suspension |
309690 | Dexamethasone 0.0005 MG/MG Ophthalmic Ointment |
309692 | Dexamethasone 1 MG/ML Ophthalmic Suspension |
388755 | Dexamethasone 1 MG/ML Topical Solution |
403908 | Ciprofloxacin 3 MG/ML / Dexamethasone 1 MG/ML Otic Suspension |
247484 | Dexamethasone 0.001 MG/MG Ophthalmic Ointment |
309679 | Dexamethasone 0.001 MG/MG / Neomycin 0.0035 MG/MG / Polymyxin B 10 UNT/MG Ophthalmic Ointment |
309682 | Dexamethasone 0.001 MG/MG / Tobramycin 0.003 MG/MG Ophthalmic Ointment |
348336 | Dexamethasone 0.001 MG/MG / Neomycin 0.0035 MG/MG Topical Ointment |
608583 | Dexamethasone 0.5 MG/ML Ophthalmic Solution |
849115 | Dexamethasone 0.5 MG/ML / Tobramycin 3 MG/ML Ophthalmic Suspension |
1009386 | Dexamethasone / Neomycin / Thiabendazole Topical Solution |
103217 | Dexamethasone Ophthalmic Ointment |
371723 | Dexamethasone Ophthalmic Suspension |
374438 | Dexamethasone / Tobramycin Ophthalmic Ointment |
374698 | Dexamethasone / Neomycin / Polymyxin B Ophthalmic Suspension |
374699 | Dexamethasone / Neomycin / Polymyxin B Ophthalmic Ointment |
377418 | Dexamethasone Ophthalmic Solution |
377456 | Dexamethasone / hypromellose Ophthalmic Solution |
378593 | Dexamethasone / Neomycin Topical Ointment |
378984 | Dexamethasone / Tobramycin Ophthalmic Suspension |
393151 | Dexamethasone Topical Solution |
405942 | Ciprofloxacin / Dexamethasone Otic Suspension |
1152113 | Ciprofloxacin / Dexamethasone Otic Product |
1154245 | Dexamethasone / Neomycin / Polymyxin B Ophthalmic Product |
1154246 | Dexamethasone / Neomycin / Thiabendazole Topical Product |
1154249 | Dexamethasone / Neomycin Topical Product |
1154524 | Dexamethasone / Tobramycin Ophthalmic Product |
1154525 | Dexamethasone / hypromellose Ophthalmic Product |
1154533 | Dexamethasone Ophthalmic Product |
1154539 | Dexamethasone Topical Product |
1170903 | Ciprodex Otic Product |
1182730 | Maxitrol Ophthalmic Product |
1182982 | Poly-Dex Ophthalmic Product |
1179099 | Tobradex Ophthalmic Product |
1179675 | Tresaderm Topical Product |
1181604 | Maxidex Ophthalmic Product |
This value set contains 61 concepts
Expansion based on RxNorm version ??
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |